Bionano Genomics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	3.73	2.99	9.17	17.95	5.09	24.57
Short-Term Investments	6.19	16.28	0.3	48.82	108.1	226.04
Cash & Short-Term Investments	9.92	19.27	9.48	66.77	113.19	250.61
Cash Growth	-39.66%	103.37%	-85.81%	-41.01%	-54.84%	551.80%
Accounts Receivable	4.37	5.2	4.75	9.32	7.02	4.93
Inventory	5.2	5.45	11.12	22.89	29.76	12.39
Other Current Assets	5.39	15.47	14.14	41.14	7.33	4.48
Total Current Assets	24.88	45.39	39.49	140.12	157.3	272.41
Net Property, Plant & Equipment	18.95	21.16	24.32	32.48	28.96	37.46
Other Intangible Assets	1.67	4.35	9.71	33.97	41.14	56.16
Goodwill	-	-	-	-	77.29	0.75
Other Long-Term Assets	2.1	2.69	3.15	7.83	2.81	11.07
Total Assets	47.59	73.58	76.67	214.4	307.5	377.1
Accounts Payable	4.56	5.59	6.96	10.38	12.53	10.77
Accrued Expenses	3.46	5.46	5.64	8.09	10.55	8.62
Short-Term Debt	-	9.98	20.36	69.8	-	-
Current Portion of Leases	0.88	0.95	3.25	2.44	2.55	1.77
Unearned Revenue	1.15	0.97	1.13	0.78	0.87	0.68
Other Current Liabilities	-	-	-	8.53	9.38	-
Total Current Liabilities	10.04	22.94	37.34	100.03	35.88	21.84
Long-Term Leases	5.83	5.97	3.68	7.18	9.12	8.93
Other Long-Term Liabilities	0.12	0.25	0.27	11.04	13.1	9.21
Total Long-Term Liabilities	5.95	6.22	3.95	18.22	22.22	18.14
Total Liabilities	15.99	29.16	41.3	118.25	58.1	39.98
Common Stock	0	0	-	-	0	0.03
Additional Paid-in Capital	766.94	764.03	728.57	677.34	599.23	553.75
Accumulated Other Comprehensive Income	0.01	0.02	0.03	0.02	-1.12	-0.54
Retained Earnings	-735.35	-719.62	-693.23	-581.21	-348.72	-216.12
Shareholders' Equity	31.61	44.42	35.38	96.16	249.4	337.12
Total Liabilities & Equity	47.59	73.58	76.67	214.4	307.5	377.1
Total Debt	6.7	16.89	27.3	79.41	11.67	10.7
Net Cash (Debt)	3.22	2.38	-17.82	-12.64	101.52	239.92
Net Cash Growth	-	-	-	-	-57.69%	984.42%
Net Cash Per Share	0.34	0.44	-14.02	-22.22	210.61	520.08
Book Value	31.61	44.42	35.38	96.16	249.4	337.12
Book Value Per Share	3.31	8.16	27.83	168.99	517.40	730.79
Tangible Book Value	29.94	40.08	25.67	62.18	130.97	280.21
Tangible Book Value Per Share	3.14	7.36	20.20	109.28	271.70	607.43

SEC Filings: 10-K · 10-Q